Attached files

file filename
EX-32.2 - EX-32.2 - Dermira, Inc.derm-ex322_175.htm
EX-31.2 - EX-31.2 - Dermira, Inc.derm-ex312_176.htm
EX-31.1 - EX-31.1 - Dermira, Inc.derm-ex311_177.htm
EX-23.1 - EX-23.1 - Dermira, Inc.derm-ex231_528.htm
EX-21.1 - EX-21.1 - Dermira, Inc.derm-ex211_527.htm
EX-10.21 - EX-10.21 - Dermira, Inc.derm-ex1021_848.htm
EX-10.20 - EX-10.20 - Dermira, Inc.derm-ex1020_129.htm
10-K - 10-K (2017 TAXONOMY) - Dermira, Inc.derm-10k_20171231.htm

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES‑OXLEY ACT OF 2002

I, Thomas G. Wiggans, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002, that, to my knowledge:

 

1.

the Annual Report of Dermira, Inc. on Form 10‑K for the year ended December 31, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.

the information contained in such Form 10‑K fairly presents, in all material respects, the financial condition and results of operations of Dermira, Inc.

 

Date: February 22, 2018

 

By:

 

/s/ Thomas G. Wiggans

 

 

 

 

Thomas G. Wiggans

Chief Executive Officer and Chairman of the Board

(Principal Executive Officer)